ASLAN Pharmaceuticals Ltd - ADR

NASDAQ:ASLN 3:59:43 PM EDT

2.61

-0.17 (-6.12%)

ASLAN Pharmaceuticals Ltd - ADR Stock, NASDAQ:ASLN

83 Clemenceau Avenue, No. 12-03 UE Square, Singapore, Central Singapore 239920

Cayman Islands

Phone: +65.6222.4235

Number of Employees: 18

http://www.aslanpharma.com

Description

Aslan Pharmaceuticals Ltd. is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and AhR Antagonist. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.